Genetic Technologies Ltd(GNTLF)

Description: Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

---

Keywords: Medicine Cancer Life Sciences Diabetes Imaging Breast Cancer Prostate Cancer Colorectal Cancer Genomics Melanoma Molecular Diagnostics Medical Genetics Personalized Medicine Genetic Testing Alternatives To Animal Testing Hereditary Cancers Ohio State University Assessment Tools Non Hereditary Breast Cancer The Ohio State University University Of Melbourne

---

Home Page: genetype.com

321 Chapel Street
Prahran, VIC 3181
Australia
Phone: 61 3 8412 7000

---

Officers

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)